9.57 Selective reporting In 2004, New York Attorney General Eliot Spitzer filed a lawsuit against GlaxoSmithKline pharmaceutical company, claiming that the company failed to publish results of one of its studies that showed that an antidepressant drug (Paxil) may make adolescents more likely to commit suicide. Partly as a consequence, editors of 11 medical journals agreed to a new policy to make researchers and companies register all clinical trials when they begin, so that negative results cannot later be covered up. The International Journal of Medical Journal Editors wrote, “Unfortunately, selective reporting of trials does occur, and it distorts the body of evidence available for clinical decision-making.” Explain why this controversy relates to the argument that it is misleading to report results only if they are “statistically significant.” (Hint: See the subsection of this chapter on misinterpretations of significance tests.)